Short Interest in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Declines By 6.0%

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 10,900 shares, a decline of 6.0% from the May 31st total of 11,600 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is presently 1.0 days.

Cryo-Cell International Price Performance

Cryo-Cell International stock opened at $7.07 on Wednesday. The firm has a market capitalization of $57.27 million, a PE ratio of -6.09 and a beta of 0.47. Cryo-Cell International has a one year low of $3.67 and a one year high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last issued its earnings results on Monday, April 15th. The company reported $0.07 EPS for the quarter. The business had revenue of $7.85 million during the quarter. Cryo-Cell International had a negative return on equity of 64.31% and a negative net margin of 31.02%.

Hedge Funds Weigh In On Cryo-Cell International

An institutional investor recently bought a new position in Cryo-Cell International stock. Rowlandmiller & PARTNERS.ADV purchased a new position in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 14,433 shares of the company’s stock, valued at approximately $108,000. Rowlandmiller & PARTNERS.ADV owned approximately 0.17% of Cryo-Cell International at the end of the most recent reporting period. 10.44% of the stock is currently owned by hedge funds and other institutional investors.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.